drugset / Trial / NCT03588806

Use of Xtampza ER to Overcome Difficulties in Swallowing Opioid Pills

NCT03588806

NaSingle-groupOpen-labelSupportive care

Summary

This study will examine how the use of Xtampza ER, an opioid analgesic packaged in openable microsphere-containing capsules, affects swallowing satisfaction, pain, and physical and mental health outcomes in chronic pain patients.

Timeline

Start
2018-05-01
Primary completion
2019-07-31
Completion
2019-10-31

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Oxycodone Other / unclassified Oral